SRDX

Surmodics Inc.

Price

return (12m)

p/e

0.00

p/bv

0.00

DIVIDEND YIELD

0.00%

SRDX price

Surmodics

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment SRDX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Profitability Comparator

If you had invested

years ago

ago, you would now have:

Fundamentals SRDX

Valuation

P/E

0.00

Sector 1.14

Industry -1.74

P/BV

0.00

Sector 1.86

Industry 1.35

P/Revenue (PSR)

Sector 1.56

Industry 2.25

EV/EBITDA

1.03

Sector -48.05

Industry -42.10

EV/EBIT

0.60

Sector -27.46

Industry -45.23

P/EBITDA

Sector -32.50

Industry -22.84

P/EBIT

Sector -43.68

Industry -27.02

P/Total Assets

Sector 0.88

Industry 0.82

P/Net Current Assets

0.00

Sector -27.11

Industry -72.49

P/Working Capital

0.00

Sector 2.78

Industry -2.12

EPS

-1.23

Sector -0.70

Industry -1.11

BVPS

7.79

Sector 4.34

Industry 2.55

Efficiency

Gross Margin

73.09%

Sector 49.36%

Industry 50.48%

EBITDA Margin

-10.02%

Sector -283.40%

Industry -17,123,193.33%

EBIT Margin

-17.13%

Sector -164.84%

Industry -17,075,660.18%

Operating Margin

-10.22%

Sector -19.73%

Industry -25.75%

Net Profit Margins

-14.59%

Sector -24.22%

Industry -27.82%

Asset Turnover

0.17

Sector 0.13

Industry 0.06

Profitability

ROE

-15.84%

Sector -24.32%

Industry -33.33%

ROA

-10.38%

Sector -24.41%

Industry -45.73%

ROIC

-14.88%

Sector -529.97%

Industry -855.00%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

3.91

Sector 1.90

Industry 2.51

Net Debt / EBITDA

1.03

Sector -4.96

Industry -8.98

Net Debt / EBIT

0.60

Sector -3.08

Industry -37.38

Net Debt / Equity

-0.03

Sector -0.45

Industry -1.16

Gross Debt / Equity

0.27

Sector -0.74

Industry -0.56

Equity/Assets

0.66

Sector 0.46

Industry 0.52

Liabilities/Assets

0.34

Sector 0.49

Industry 0.47

Growth

5Y Revenue CAGR

2.68%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals SRDX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
SRDX Surmodics Inc.	$0.00	-100.00%	0.00%	0.00	0.00	-15.84%	-14.59%
ISRG Intuitive Surgical Inc.	$393.33	-10.35%	0.00%	44.01	7.60	17.26%	28.62%
ABT Abbott Laboratories	$102.61	-22.85%	2.25%	35.46	3.76	10.61%	11.65%
MDT Medtronic PLC	$92.13	0.84%	3.11%	22.28	2.31	10.35%	14.02%
BSX Boston Scientific Corp.	$43.34	-55.70%	0.00%	17.60	2.59	14.73%	17.49%
TMDX TransMedics Group Inc.	$86.42	-29.33%	0.00%	19.94	5.84	29.28%	22.69%
RMD ResMed Inc.	$224.99	-16.77%	0.80%	21.51	4.98	23.13%	26.94%
IDXX IDEXX Laboratories Inc.	$511.65	-22.02%	0.00%	35.48	25.07	70.67%	25.03%
COHR Coherent Inc.	$317.36	190.86%	0.00%	75.62	5.36	7.09%	11.19%
SYK Stryker Corp.	$275.12	-26.01%	1.26%	28.38	4.41	15.55%	14.43%
PHG Koninklijke Philips NV	$24.69	-8.66%	4.11%	18.19	1.78	9.80%	6.30%
INMD InMode Ltd.	$14.35	-2.38%	0.00%	10.90	1.34	12.32%	20.69%
DXCM DexCom Inc.	$89.35	32.47%	0.00%	33.89	12.92	38.14%	20.12%
BDX Becton Dickinson and Company	$180.94	-0.31%	2.34%	52.21	2.01	3.86%	6.30%
EW Edwards Lifesciences Corp.	$88.26	18.61%	0.00%	50.69	4.74	9.36%	15.41%
ALGN Align Technology Inc.	$147.61	12.34%	0.00%	27.43	2.68	9.77%	9.99%
SNN Smith & Nephew PLC	$27.58	-22.60%	2.80%	19.48	4.52	23.22%	9.83%
IRMD iRadimed Corporation	$82.12	17.79%	1.54%	45.76	10.37	22.66%	26.70%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

SRDX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Surmodics

Surmodics Inc.

Average Investor10 user rating

4.0 (0 people)

United States

47 years

Founded: 1979

1998

Time since IPO - 28 years

389

Employees

Surmodics Inc. (United States) is listed on the Nasdaq and has a market capitalization of $-, with shareholders equity totaling $111.31 million.

The company employs approximately 389 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Surmodics Inc. reported $120.80 million in revenue, generating net income of $-17.63 million.

Key financial metrics include a P/E ratio of 0.00, a price-to-book (P/B) ratio of 0.00, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker SRDX.

Market cap

Net worth

$111.31 million

$111,309,000.00

Assets

$169.82 million

$169,822,000.00

Total Shares Outstanding

14.28 million

14,281,000

Average Daily Trading Volume

$462.97 Thousand

$462,972.32

Sector

Health

Industry

Medical Supplies and Equipment

SRDX

SRDX revenue and profits

Financial Results SRDX

DRAG THE FRAME TO SEE MORE DATA

SRDX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$88.84 22,33% (12M)

P/E

-0.79

3.01%

ROE

-178.93%

P/BV

1.42

CI - Cigna

$275.28 --3,05% (12M)

P/E

10.57

1.69%

ROE

16.04%

P/BV

1.70

CNC - Centene

$65.11 104,94% (12M)

P/E

-6.38

0.00%

ROE

-22.56%

P/BV

1.44

HUM - Humana

$386.22 55,41% (12M)

P/E

35.53

0.93%

ROE

6.72%

P/BV

2.39

SNY - Sanofi

$42.48 --7,32% (12M)

P/E

3.97

4.17%

ROE

18.43%

P/BV

0.73

LLY - Eli Lilly

$1,152.93 54,29% (12M)

P/E

38.16

0.59%

ROE

78.84%

P/BV

30.09

HCA - HCA Healthcare

$427.71 7,02% (12M)

P/E

12.06

0.70%

ROE

-244.72%

P/BV

-29.52

NVS - Novartis

$140.37 16,41% (12M)

P/E

20.89

2.22%

ROE

30.39%

P/BV

6.35